Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

NCT00066443 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

93

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: pegfilgrastim
DRUG: docetaxel
DRUG: epirubicin hydrochloride

Sponsor

NCIC Clinical Trials Group